ANORMED REPORTS FISCAL 2006 FIRST QUARTER RESULTS, PROGRESS ON PHASE III TRIALS

AnorMED Inc. (TSX:AOM) today reported financial results for its first fiscal quarter ended June 30, 2005. AnorMED recorded a net loss of $8,025,000 ($0.25 per common share) in this quarter. This is in comparison to the net losses incurred in the previous fiscal quarter ended March 31, 2005 of $7,619,000 ($0.24 per common share) and the prior year's first quarter, ended June 30, 2004, of $3,814,000 ($0.12 per common share).

Canada NewsWire Group (http://www.newswire.ca/en/releases/archive/August2005/02/c6344.html)